about
Berberine inhibits HIV protease inhibitor-induced inflammatory response by modulating ER stress signaling pathways in murine macrophagesDebio 025, a cyclophilin binding molecule, is highly efficient in clearing hepatitis C virus (HCV) replicon-containing cells when used alone or in combination with specifically targeted antiviral therapy for HCV (STAT-C) inhibitorsThe bile acid sensor FXR protects against dyslipidemia and aortic plaques development induced by the HIV protease inhibitor ritonavir in miceSynthesis, X-ray Analysis, and Biological Evaluation of a New Class of Stereopure Lactam-Based HIV-1 Protease InhibitorsReduced adipogenic gene expression in thigh adipose tissue precedes human immunodeficiency virus-associated lipoatrophy.Higher levels of Zidovudine resistant HIV in the colon compared to blood and other gastrointestinal compartments in HIV infection.In silico modeling indicates the development of HIV-1 resistance to multiple shRNA gene therapy differs to standard antiretroviral therapy.Basic quinolinonyl diketo acid derivatives as inhibitors of HIV integrase and their activity against RNase H function of reverse transcriptase.Effective inhibition of human immunodeficiency virus 1 replication by engineered RNase P ribozyme.Multiple shRNA combinations for near-complete coverage of all HIV-1 strains6-Benzoyl-3-hydroxypyrimidine-2,4-diones as dual inhibitors of HIV reverse transcriptase and integrase.3-Hydroxypyrimidine-2,4-diones as an inhibitor scaffold of HIV integraseA quantitative comparison of anti-HIV gene therapy delivered to hematopoietic stem cells versus CD4+ T cells.Biochemistry and biophysics of HIV-1 gp41 - membrane interactions and implications for HIV-1 envelope protein mediated viral-cell fusion and fusion inhibitor designRelationship of plasma cytokines and clinical biomarkers to memory performance in HIVHuman immunodeficiency virus type 1 variants resistant to first- and second-version fusion inhibitors and cytopathic in ex vivo human lymphoid tissue.A simple, efficient, and sensitive method for simultaneous detection of anti-HIV drugs atazanavir, ritonavir, and tenofovir by use of liquid chromatography-tandem mass spectrometry.RNase P-associated external guide sequence effectively reduces the expression of human CC-chemokine receptor 5 and inhibits the infection of human immunodeficiency virus 1Design, Synthesis, and Biological Evaluations of Hydroxypyridonecarboxylic Acids as Inhibitors of HIV Reverse Transcriptase Associated RNase H.Effect of a single dose of ritonavir on the pharmacokinetic behavior of elvucitabine, a nucleoside reverse transcriptase inhibitor, administered in healthy volunteers.A review of the use of complementary and alternative medicine and HIV: issues for patient care.Insights into HIV-1 proviral transcription from integrative structure and dynamics of the Tat:AFF4:P-TEFb:TAR complex.Body mass index, inflammatory biomarkers and neurocognitive impairment in HIV-infected persons.Dual inhibition of HCV and HIV by ring-expanded nucleosides containing the 5:7-fused imidazo[4,5-e][1,3]diazepine ring system. In vitro results and implications.Targeting human immunodeficiency virus type 1 assembly, maturation and budding.Double-Winged 3-Hydroxypyrimidine-2,4-diones: Potent and Selective Inhibition against HIV-1 RNase H with Significant Antiviral Activity.Novel liquid chromatography-tandem mass spectrometry method for simultaneous detection of anti-HIV drugs Lopinavir, Ritonavir, and Tenofovir in plasma.Identification of a critical motif for the human immunodeficiency virus type 1 (HIV-1) gp41 core structure: implications for designing novel anti-HIV fusion inhibitors.6-Cyclohexylmethyl-3-hydroxypyrimidine-2,4-dione as an inhibitor scaffold of HIV reverase transcriptase: Impacts of the 3-OH on inhibiting RNase H and polymerase.Cutaneous Adverse Reactions to Highly Antiretroviral Therapy in HIV-Positive Patients.Concomitant administration of BILR 355/r with emtricitabine/tenofovir disoproxil fumarate increases exposure to emtricitabine and tenofovir: a randomized, open-label, prospective study.HIV protease inhibitors activate the unfolded protein response and disrupt lipid metabolism in primary hepatocytes.High-Technology Therapy Using Biomolecules or Synthetic Compounds for HIV InhibitionStructural basis of antiviral activity of peptides from MPER of FIV gp36
P2860
Q21142660-1A691577-FB94-438F-8A5B-E169CB6F7E5FQ24645702-B2AD24DF-B698-471A-B6BD-A1BF79D2AB93Q27318414-370CF492-6EB2-474B-A4AA-6AAEFD00ACB5Q27677537-B738853E-1F73-4B0F-9067-6FFFC1BFE736Q30481446-13AE0D54-FFF0-41DF-B9B5-AD3706D03FDDQ34173947-B84F8D4E-9F9B-4BB6-89A4-AF9D0A520E4FQ34221633-22A27DDC-1074-4B35-8505-815F26AB6C64Q34372481-8BCCD096-2B01-4C32-BA0D-A2C6D6A92C71Q34540271-D6224354-1CD8-47A9-B323-07A364A849B1Q34552467-93379561-77E5-40AF-8BE7-C0F5E4FF4933Q34762297-E59E59B0-8F30-42B0-88F2-8DA579F96796Q34770674-56AADF4C-0672-4E26-AB87-08CD52710BCEQ35191116-B3DA3D50-A06D-4B6B-A6B1-42BCB578BFC7Q35563298-9AB89F90-D1AE-4660-9A14-F2F1022C67E5Q35576425-838BE3A6-EE32-4E77-AF02-D45235B98E7DQ35857279-615BDD22-CF34-4309-9CE0-C933DAFB8E1DQ36158376-CB91B7E2-4E42-432E-B7BA-7B497373660DQ36665338-C68A18AF-312E-46D0-9A87-B23809D9B9D8Q36940608-5FEB8511-BE5F-4B83-9533-F1C76309C9BDQ37072082-DD371B66-A0FA-4875-BA35-BD1953226DA4Q37139462-797FC772-2D37-4241-AF4B-9E19562ECB23Q37354566-A068D5C0-17FA-494D-AB45-B4678A057237Q37520967-29E18628-9F94-4114-999F-816CA52DD9C4Q37691512-1AA439F4-6B33-44F2-8330-C14AC45BDB98Q37928913-E903F8C4-55DB-4D2D-ABC0-DC44FA7F47D0Q38702915-8372D3DB-C97D-47CE-907B-1628289A81BAQ38849285-7B1ACD83-C8AE-44EF-AA08-34AAB8D39186Q39766027-38751EC6-E68F-4182-BB82-630DCEC972DCQ40338429-43DB3977-F864-46FD-BB74-A5CD0667002BQ40426345-D2B45C61-A9C6-4F9D-B1F5-E05026032306Q42679799-3B93126C-1B7E-49CA-9FE4-C9A97EC01695Q44922052-83D4E28B-A841-44BF-B4A4-695B007BA75EQ55652601-8EF58706-DBAC-4464-9B0E-71C7CC44B3E1Q58707483-D5FFDED4-E148-42F2-96F5-1A553183C09D
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Update on HAART in HIV.
@ast
Update on HAART in HIV.
@en
type
label
Update on HAART in HIV.
@ast
Update on HAART in HIV.
@en
prefLabel
Update on HAART in HIV.
@ast
Update on HAART in HIV.
@en
P1476
Update on HAART in HIV.
@en
P2093
Patrick Yeni
P304
P356
10.1016/J.JHEP.2005.11.021
P433
P577
2005-11-28T00:00:00Z